twitter

Wednesday, 18 May 2016

Electrocardiographic and Blood Pressure Effects of Energy Drinks and Panax ginseng in Healthy Volunteers: A Randomized Clinical Trial


Abstract

Background

Energy drink usage has been linked to emergency room visits and deaths. The objective of the study is to assess the electrocardiographic and blood pressure effects of energy drinks, Panax ginseng and placebo in healthy individuals.

Methods

This was a randomized, double blinded, placebo controlled, crossover study. Young healthy volunteers with no comorbid conditions consumed 32 oz of an energy drink, control drink with 800 mg of Panax ginseng or matching placebo-control drink over 45 min. Primary endpoints were QTc interval and systolic blood pressure. Secondary endpoints included QT interval, PR interval, QRS duration, heart rate, and diastolic blood pressure. All endpoints were assessed at baseline, 1, 2, 3.5, and 5.5 h.

Results

A significant increase in QTc interval 2 h post energy drink consumption was evident when compared to placebo (3.37 ± 10.7 msec and − 3.19 ± 11.8 msec respectively; p = 0.030). Similarly, systolic blood pressure 2 h post energy drink consumption increased when compared to placebo (2.00 ± 6.37 mmHg and − 2.67 ± 5.83 mmHg respectively; p = 0.014). The PR interval significantly reduced over a 2 h period post energy drink use in a clinically non-meaningful manner. Heart rate at 2 h was not significantly higher in the energy drink group when compared to others. The QT interval, QRS interval and diastolic blood pressure were not impacted at any time point.

Conclusions

Certain energy drinks consumed at a high volume significantly increase the QTc interval and systolic blood pressure by over 6 msec and 4 mmHg respectively. Panax ginsengdoes not have a significant impact on ECG or blood pressure parameters.

Keywords

  • electrocardiography
  • electrophysiology
  • arrhythmia
  • blood pressure
  • energy drink
Funding: This study was funded by a University of the Pacific, Eberhardt Research Fellowship grant who had no additional role in the study.
☆☆
Conflicts of interest: None
Corresponding author at: University of the Pacific, Thomas J Long School of Pharmacy and Health Sciences, 3601 Pacific Ave, Stockton, CA, 95204., United States.
1
This author takes responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation.

Note to users: